Delivery Order SPE2DB20D3111-SPE2DB25FA8ZX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,930.56 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Escitalopram 10 mg, a generic selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety disorders. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.89 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,819.74 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 20 mg, a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression and anxiety disorders. The contract, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, utilizes firm fixed pricing and carries no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,507.57 to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 count) on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Escitalopram is a selective serotonin reuptake inhibitor commonly prescribed for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Escitalopram 20 mg tablets (1,000 count) valued at $2,912.46. This non-competitive, firm fixed-price delivery order was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Escitalopram is a selective serotonin reuptake inhibitor commonly used to treat depression and...
- The Defense Logistics Agency awarded a $1,627.52 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with performance scheduled for completion by September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. This award...
- The U.S. Department of Defense, through its Medical Supply Chain organization, awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Escitalopram 10mg tablets in a quantity of 1,000 units. This firm fixed-price delivery order, valued at $3,103.26, represents a non-competitive set-aside award and is scheduled for completion by October 1, 2025. The performance location is AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty thousand one hundred five dollars and sixty-four cents ($20,105.64) to Amerisourcebergen Drug Corporation for the delivery of one thousand (1,000) units of escitalopram tablets, a selective serotonin reuptake inhibitor prescribed for depression and anxiety. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 24-25, 2023. No set aside...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,381.08, is for the supply of Escitalopram 10mg tablets, a prescription medication used to treat depression and anxiety disorders. The contract has an ultimate completion date of May 14, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Escitalopram 20 mg tablets in a quantity of 1,000 units, with a firm fixed price ceiling value of $4,295.66. The contract represents a non-set-aside, competitively awarded procurement with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA8ZXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders. This firm fixed price delivery order, valued at $1,096.85, was competitively awarded without set-aside provisions and is scheduled for completion by August 21, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999.99 million and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The award demonstrates the company's established capability to fulfill federal pharmaceutical procurement requirements through its extensive portfolio of generic and brand-name medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/20/25 |